Needham & Company Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Soliris sBLA for aHUS Gets Priority Review – A Positive Yet Well Expected News
Tweet Send to a Friend
Needham & Company maintains a 'Hold' on Alexion Pharmaceuticals (NASDAQ: ALXN).
Needham analyst said, "We believe the news, while widely ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst said, "We believe the news, while widely ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
